Recent data showed that polymorphism in the upstream IFNL4 gene, besides that in the IL28B (IFNλ3) gene, influences necro-inflammation severity and liver fibrosis progression in CHC patients [36,37]. The gene discussed is IFNL3; the disease is Hepatic fibrosis.